Gene Transfer of Extracellular Superoxide Dismutase Ameliorates Pulmonary Hypertension in Rats
Overview
Authors
Affiliations
Rationale: Pulmonary hypertension (PH) is a life-threatening disease, characterized by vascular remodeling and vasoconstriction. Evidence suggests that oxidative stress may contribute to the pathogenesis and/or development of PH.
Objectives: In the present study, we examined whether intratracheal gene transfer of human extracellular superoxide dismutase (EC-SOD) could ameliorate monocrotaline (MCT)-induced PH in rats.
Methods: MCT-injected rats were intratracheally administered vehicle (MCT group) or an adenovirus encoding beta-galactosidase (Adbetagal group) or human EC-SOD (AdEC-SOD group).
Measurements And Main Results: After intratracheal gene transfer, EC-SOD was successfully expressed in lung tissue, bronchoalveolar lavage fluid, and plasma. Twenty-eight days after MCT injection, right ventricular systolic pressure and the weight ratio of the right ventricle to the left ventricle plus septum were significantly lower in the AdEC-SOD group (42.50 +/- 1.46 mm Hg and 0.453 +/- 0.029, respectively) than in the MCT group (59.89 +/- 1.61 mm Hg and 0.636 +/- 0.022, respectively) or the Adbetagal group (61.50 +/- 2.61 mm Hg and 0.653 +/- 0.038, respectively). Moreover, vascular remodeling and proliferation of vascular smooth muscle cells in pulmonary arteries were markedly suppressed in the AdEC-SOD group. Importantly, 8-isoprostane in lung tissue was also significantly reduced in the AdEC-SOD group.
Conclusions: EC-SOD overexpression to the lung ameliorated MCT-induced PH in rats. We suggest that EC-SOD may act as an antioxidant in PH and that increased oxidative stress may be important in the pathogenesis of MCT-induced PH.
Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling.
Fang Q, Bai Y, Hu S, Ding J, Liu L, Dai M Antioxidants (Basel). 2023; 12(11).
PMID: 38001831 PMC: 10669195. DOI: 10.3390/antiox12111978.
Oxidative Stress, Antioxidants and Hypertension.
Amponsah-Offeh M, Diaba-Nuhoho P, Speier S, Morawietz H Antioxidants (Basel). 2023; 12(2).
PMID: 36829839 PMC: 9952760. DOI: 10.3390/antiox12020281.
Wei R, Lv X, Fang C, Liu C, Ma Z, Liu K Oxid Med Cell Longev. 2022; 2022:4931611.
PMID: 35936222 PMC: 9348918. DOI: 10.1155/2022/4931611.
Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Jiang W, Han X, Zhang Y, Xia Q, Zhang J, Wang F RSC Adv. 2022; 9(1):552-559.
PMID: 35521617 PMC: 9059326. DOI: 10.1039/c8ra07892k.
Xie S, Deng Y, Guo S, Li J, Zhou Y, Liao J Sci Rep. 2022; 12(1):3056.
PMID: 35197507 PMC: 8866506. DOI: 10.1038/s41598-022-06848-7.